找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Neuroimmunology; Multiple Sclerosis, Amanda L. Piquet,Enrique Alvarez Book 2021 Springer Nature Switzerland AG 2021 Neuroimmunology.Multip

[復(fù)制鏈接]
查看: 7396|回復(fù): 58
樓主
發(fā)表于 2025-3-21 17:22:13 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Neuroimmunology
副標(biāo)題Multiple Sclerosis,
編輯Amanda L. Piquet,Enrique Alvarez
視頻videohttp://file.papertrans.cn/665/664101/664101.mp4
概述Focuses on various neuroinflammatory diseases, including multiple sclerosis, immune-mediated neurological diseases and autoimmune neurological disease.Reviews pathophysiology and treatment approaches.
圖書封面Titlebook: Neuroimmunology; Multiple Sclerosis,  Amanda L. Piquet,Enrique Alvarez Book 2021 Springer Nature Switzerland AG 2021 Neuroimmunology.Multip
描述.This book provides a clinical focus on neuroinflammatory diseases as well as a review in pathophysiology and treatment approaches...Organized into six parts, the book begins with a basic review of the immune system and concepts for learning and treating neuroimmune conditions. The next four sections cover specific subfields of neuroimmunology and autoimmune neurology - the clinical and diagnostic features of multiple sclerosis, other autoimmune conditions of the central nervous system, autoimmune conditions of the peripheral nervous system, and systemic autoimmune conditions that affect the nervous system. To conclude, Section six discusses various clinical approaches to specific presentations in neuroimmunology, including pediatric demyelinating diseases.? These sections provide practical clinical information to improve the reader’s knowledge in this complex field. The chapters are written by world renown authors with extensive knowledge to help provide up to date information. The full scope of autoimmune neurology is discussed, which is a unique feature of this book...Neuroimmunology. serves as a resource for those in training including residents and fellows to provide clear cli
出版日期Book 2021
關(guān)鍵詞Neuroimmunology; Multiple Sclerosis; Autoimmune Neurology; Immunology; Central Nervous System inflammato
版次1
doihttps://doi.org/10.1007/978-3-030-61883-4
isbn_softcover978-3-030-61885-8
isbn_ebook978-3-030-61883-4
copyrightSpringer Nature Switzerland AG 2021
The information of publication is updating

書目名稱Neuroimmunology影響因子(影響力)




書目名稱Neuroimmunology影響因子(影響力)學(xué)科排名




書目名稱Neuroimmunology網(wǎng)絡(luò)公開度




書目名稱Neuroimmunology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Neuroimmunology被引頻次




書目名稱Neuroimmunology被引頻次學(xué)科排名




書目名稱Neuroimmunology年度引用




書目名稱Neuroimmunology年度引用學(xué)科排名




書目名稱Neuroimmunology讀者反饋




書目名稱Neuroimmunology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:38:39 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:22:59 | 只看該作者
地板
發(fā)表于 2025-3-22 05:01:45 | 只看該作者
https://doi.org/10.1007/978-3-030-61883-4Neuroimmunology; Multiple Sclerosis; Autoimmune Neurology; Immunology; Central Nervous System inflammato
5#
發(fā)表于 2025-3-22 09:06:12 | 只看該作者
6#
發(fā)表于 2025-3-22 13:51:18 | 只看該作者
7#
發(fā)表于 2025-3-22 19:29:47 | 只看該作者
Neuroimaging Modalities in Neuroimmunologyple sclerosis (MS). MRI is highly sensitive to visualize white matter signal abnormalities on T2-weighted images, and the characteristic appearance of demyelinating lesions has become well recognized. However, MRI is not pathologically specific, and differentiating MS from other (non-MS) conditions
8#
發(fā)表于 2025-3-22 21:21:27 | 只看該作者
Clinical Trial Design in Neuroimmunologyd great insights into these conditions resulting in the approval of disease-modifying therapies (DMTs) for multiple sclerosis (MS) and neuromyelitis optica spectrum disease (NMOSD) along with symptomatic therapies such as dalfampridine. Treatment of relapsing-remitting MS (RRMS) has seen dramatic ch
9#
發(fā)表于 2025-3-23 02:25:43 | 只看該作者
Concepts of Immune Therapy and Disease Managementd should be promptly recognized for early treatment and optimization of chronic immunomodulating or immunosuppressing therapies to avoid disability accumulation over time. Detection of subclinical activity using paraclinical testing also warrants a change in treatment and should be part of the monit
10#
發(fā)表于 2025-3-23 08:11:02 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 06:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金堂县| 东明县| 云林县| 林西县| 昌黎县| 托里县| 汝阳县| 瓦房店市| 彭州市| 黄浦区| 大埔县| 河北省| 高平市| 梅河口市| 平原县| 图木舒克市| 铜川市| 托里县| 平南县| 台山市| 光山县| 清流县| 任丘市| 开江县| 鹤壁市| 宁陕县| 泰顺县| 旅游| 泰宁县| 龙门县| 滦平县| 呼玛县| 灵武市| 长汀县| 云安县| 沐川县| 乡宁县| 高安市| 荣昌县| 襄垣县| 故城县|